<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Int (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Med Int (Lond)</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title-group><journal-title>Medicine International</journal-title></journal-title-group><issn pub-type="ppub">2754-3242</issn><issn pub-type="epub">2754-1304</issn><publisher><publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11863295</article-id><article-id pub-id-type="publisher-id">MI-5-3-00221</article-id><article-id pub-id-type="doi">10.3892/mi.2025.221</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Frequency of vasovagal reactions in whole blood donation and contributing factors</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Dem&#x00069;&#x00307;rc&#x00069;&#x00307;o&#x0011f;lu</surname><given-names>S&#x00069;&#x00307;nan</given-names></name><xref rid="af1-MI-5-3-00221" ref-type="aff">1</xref><xref rid="c1-MI-5-3-00221" ref-type="corresp"/></contrib><contrib contrib-type="author"><name><surname>T&#x000fc;rk</surname><given-names>Al&#x00069;&#x00307;</given-names></name><xref rid="af2-MI-5-3-00221" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Tomruk</surname><given-names>At&#x00069;&#x00307;lla</given-names></name><xref rid="af2-MI-5-3-00221" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Dem&#x00069;&#x00307;rc&#x00069;&#x00307;o&#x0011f;lu</surname><given-names>Havva</given-names></name><xref rid="af3-MI-5-3-00221" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Tek&#x00069;&#x00307;nalp</surname><given-names>Atakan</given-names></name><xref rid="af1-MI-5-3-00221" ref-type="aff">1</xref></contrib></contrib-group><aff id="af1-MI-5-3-00221"><label>1</label>Department of Hematology, Faculty of Medicine, Necmettin Erbakan University, Konya 42090, Turkey</aff><aff id="af2-MI-5-3-00221"><label>2</label>Transfusion Center, Faculty of Medicine, Necmettin Erbakan University, Konya 42090, Turkey</aff><aff id="af3-MI-5-3-00221"><label>3</label>Meram Family Health Center No. 25, Konya 42090, Turkey</aff><author-notes><corresp id="c1-MI-5-3-00221"><italic>Correspondence to:</italic> Dr Sinan Demircio&#x0011f;lu, Department of Hematology, Faculty of Medicine, Necmettin Erbakan University, 281 Bey&#x0015f;ehir Street, Konya 42090, Turkey <email>ronger090614@126.com sinandemircioglumd@gmail.com </email></corresp></author-notes><pub-date pub-type="collection"><season>May-Jun</season><year>2025</year></pub-date><pub-date pub-type="epub"><day>18</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>2</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>5</volume><issue>3</issue><elocation-id>22</elocation-id><history><date date-type="received"><day>24</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>02</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2025 Demircio&#x0011f;lu et al.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license></permissions><abstract><p>The aim of the present study was to identify the frequency of vasovagal reactions (VVRs) and the factors influencing their occurrence. For this purpose, a total of 742 donors who applied for whole blood donation at a blood center were included in the study. The frequency of VVR and its association with donor-related factors were assessed. The results revealed that the median age of the donors was 36 years, with 9.8% female and 90.2% male donors. VVRs were observed in 4.9% of the donors. The median age of the donors who experienced VVRs was found to be lower than that of those who did not experience VVRs. The incidence of VVRs was higher in first-time donors. The median blood donation rate for donors who experienced VVRs was 2, compared to 4 for those who did not, and the difference was statistically significant. On the whole, the present study demonstrates that the frequency of VVRs is higher in first-time blood donors, and that the blood donation rate is lower for those who experience VVRs. Preventive measures for VVRs, particularly for first-time donors, could increase the rate of blood donation.</p></abstract><kwd-group><kwd>whole blood</kwd><kwd>blood donation</kwd><kwd>vasovagal reactions</kwd><kwd>transfusion</kwd><kwd>hemovigilance</kwd></kwd-group><funding-group><funding-statement><bold>Funding:</bold> No funding was received.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Although blood donation is generally a safe procedure, undesirable reactions can occur during or after the collection of whole blood or blood components. The most common adverse event is a vasovagal reaction (VVR; or vasovagal syncope). VVRs are considered to be triggered by various physical (e.g., standing up after losing 500 ml blood) and psychological stimuli (e.g., pain, stress and fear) (<xref rid="b1-MI-5-3-00221" ref-type="bibr">1</xref>). During a VVR, there is a decrease in the arterial blood pressure and cerebral perfusion of the donor, which reduces the blood flow to the brain (<xref rid="b2-MI-5-3-00221" ref-type="bibr">2</xref>). The highest frequency of VVRs in whole blood donors occurs during needle removal and when leaving the donation chair (<xref rid="b3-MI-5-3-00221" ref-type="bibr">3</xref>). A small proportion (9-12%) of reported VVRs occurs after the donor leaves the center. However, the number of off-site reactions is often underestimated due to underreporting by donors (<xref rid="b4-MI-5-3-00221" ref-type="bibr">4</xref>). The symptoms of VVRs include general weakness, dizziness, pallor, sweating, anxiety and nausea; additionally, some donors may experience more severe symptoms, such as a transient loss of consciousness (syncope), convulsions, or incontinence (<xref rid="b5-MI-5-3-00221" ref-type="bibr">5</xref>). Fainting and falling can result in accidental injuries. VVRs also prevent individuals from donating again, decreasing the likelihood of repeat donations by &#x0003e;50% (<xref rid="b6-MI-5-3-00221" ref-type="bibr">6</xref>,<xref rid="b7-MI-5-3-00221" ref-type="bibr">7</xref>).</p><p>VVRs affect donor safety and future donation behavior. They also negatively affect donor waiting times, appointment management and the number of completed blood collections (<xref rid="b7-MI-5-3-00221" ref-type="bibr">7</xref>). Therefore, risk factors for VVR need to be identified, and preventive policies need to be developed. The present study aimed to investigate the frequency and causes of VVR in whole blood donors at the Transfusion Center, Faculty of Medicine, Necmettin Erbakan University.</p></sec><sec sec-type="Subjects|methods"><title>Subjects and methods</title><sec><title>Donor information</title><p>A total of 742 donors who applied for whole blood donation at the Necmettin Erbakan University Transfusion Center (Konya, Turkey) were included in the study. The present study was conducted between September and October, 2024. Donor eligibility was evaluated according to the National Blood and Blood Component Preparation, Use, and Quality Assurance Guide (<xref rid="b8-MI-5-3-00221" ref-type="bibr">8</xref>). All donors were provided with information about the donation process prior to the donation. Potential complications were explained. At this stage, those who decided to withdraw from blood donation were not pressured to continue. Following the donation, donors were taken to the rest area where they were served fruit juice and encouraged to sit and rest for 15 min. In cases of VVR, necessary interventions were performed by the doctor. To assess the health status of the donors and determine their eligibility for blood donation, blood pressure, body temperature, and pulse rate were measured prior to the donation.</p><p>An average of 450&#x000b1;45 cc of whole blood was collected from the donors. Donor age, sex, comorbidities, fasting status, time since last meal, blood donation history, leukocyte count, hemoglobin level and platelet count were recorded. The frequency and timing of VVRs were determined, and the association between VVRs and the donor characteristics was analyzed. The present study was approved by the Necmettin Erbakan University, Ethics Committee for Non-Pharmaceutical and Non-Medical Device Research (2024-5381). Written consent was obtained from the participants.</p></sec><sec><title>Statistical analysis</title><p>Statistical analysis was performed using the SPSS IBM program, version 23.0 (IBM Corp.). The distribution characteristics of continuous variables were evaluated using the Kolmogorov-Smirnov test. Descriptive statistics for normally distributed data are expressed as the mean &#x000b1; standard deviation, while non-normally distributed data are presented as the median (range). Group comparisons for continuous variables were conducted using the Mann-Whitney U test. Categorical variables are expressed as percentages (%) and compared using the Fisher's test. Values of P&#x0003c;0.05 were considered to indicate a statistically significant difference.</p></sec></sec><sec sec-type="Results"><title>Results</title><p>A total of 742 blood donors were evaluated. The median age of the donors was 36 years (range, 18-67 years), with 69 (9.8%) female and 673 (90.2%) male donors. The median age of the donors was similar between the male and female donors (35 years vs. 36 years).</p><p>VVR was detected in 37 (4.9%) donors. A total of 7 out of 62 females (10.1%) and 30 out of 643 males (4.45%) developed VVR, with no significant difference. The median age of the donors who experienced VVR was significantly lower than that of those who did not (P=0.04). Of note, 16% of the donors (119 individuals) were first-time donors. VVRs developed in 10% (12 individuals) of the first-time donors. First-time blood donors had a higher incidence of VVR (32.4% vs. 15.2%, P=0.010) (<xref rid="f1-MI-5-3-00221" ref-type="fig">Fig. 1</xref>). The median blood donation rate for donors who experienced VVRs was 2, compared to 4 for those who did not, and this difference was statistically significant (P&#x0003c;0.001) (<xref rid="tI-MI-5-3-00221" ref-type="table">Table I</xref>). No significant effects of fasting status, sex, comorbidities, leukocyte count, hemoglobin, hematocrit, or platelet count on VVRs were found (<xref rid="tI-MI-5-3-00221" ref-type="table">Table I</xref>). As regards the timing of VVRs, among the 37 donors who experienced VVRs, 14 (37.8%) had it during the donation, and 23 (62.2%) after the donation. First-time donors had a higher rate of VVR during the donation (57.1% vs. 17.4%, P=0.027) (<xref rid="tI-MI-5-3-00221" ref-type="table">Table I</xref> and <xref rid="f2-MI-5-3-00221" ref-type="fig">Fig. 2</xref>).</p></sec><sec sec-type="Discussion"><title>Discussion</title><p>In blood donation, moderate VVRs occur in 1.4 to 7% of individuals, and severe VVRs occur in 0.1 to 0.5% of cases (<xref rid="b4-MI-5-3-00221" ref-type="bibr">4</xref>,<xref rid="b9-MI-5-3-00221" ref-type="bibr">9-18</xref>). The present study found a VVR rate of 4.9%, which is similar to that observed in the literature. The hospitalization rate due to blood donation complications has been reported as 1/198,000, with two-thirds of these events associated with VVRs. Falls leading to injuries have been found to be the most significant cause in female donors (<xref rid="b4-MI-5-3-00221" ref-type="bibr">4</xref>). None of the donors in the present study required hospitalization.</p><p>The following risk factors have been shown to be associated with an increased risk of VVRs: The female sex (<xref rid="b7-MI-5-3-00221" ref-type="bibr">7</xref>,<xref rid="b19-MI-5-3-00221" ref-type="bibr">19</xref>,<xref rid="b20-MI-5-3-00221" ref-type="bibr">20</xref>), a low body weight (<xref rid="b21-MI-5-3-00221" ref-type="bibr">21</xref>,<xref rid="b22-MI-5-3-00221" ref-type="bibr">22</xref>), a low estimated blood volume (<xref rid="b9-MI-5-3-00221" ref-type="bibr">9</xref>,<xref rid="b20-MI-5-3-00221" ref-type="bibr">20</xref>,<xref rid="b23-MI-5-3-00221" ref-type="bibr">23</xref>), a younger age (<xref rid="b7-MI-5-3-00221" ref-type="bibr">7</xref>,<xref rid="b9-MI-5-3-00221" ref-type="bibr">9</xref>,<xref rid="b19-MI-5-3-00221" ref-type="bibr">19</xref>,<xref rid="b23-MI-5-3-00221" ref-type="bibr">23</xref>), first-time donation (<xref rid="b7-MI-5-3-00221" ref-type="bibr">7</xref>,<xref rid="b19-MI-5-3-00221" ref-type="bibr">19</xref>,<xref rid="b22-MI-5-3-00221" ref-type="bibr">22</xref>,<xref rid="b23-MI-5-3-00221" ref-type="bibr">23</xref>), a low resting blood pressure (<xref rid="b21-MI-5-3-00221" ref-type="bibr">21</xref>), insufficient sleep prior to donation (<xref rid="b24-MI-5-3-00221" ref-type="bibr">24</xref>,<xref rid="b25-MI-5-3-00221" ref-type="bibr">25</xref>), donation site (<xref rid="b23-MI-5-3-00221" ref-type="bibr">23</xref>) and a history of symptoms during previous donations (<xref rid="b26-MI-5-3-00221" ref-type="bibr">26</xref>,<xref rid="b27-MI-5-3-00221" ref-type="bibr">27</xref>). The frequency of VVRs has been found to be higher in first-time, young and female donors (<xref rid="b21-MI-5-3-00221" ref-type="bibr">21</xref>,<xref rid="b28-MI-5-3-00221" ref-type="bibr">28</xref>,<xref rid="b29-MI-5-3-00221" ref-type="bibr">29</xref>). Additionally, donors who experienced VVRs had a significantly lower total blood donation count. This may be due to regular donations from those who did not experience VVRs in previous donations, while those who experienced VVRs tend to avoid further donations. Unlike other studies, the female sex was not found to be a risk factor for VVRs in the present study, possibly due to the smaller number of female donors. The primary reason for the low number of female donors is iron deficiency anemia, which develops in menstruating women. Iron deficiency affects 29 to 58% of healthy females of reproductive age, while the prevalence of iron deficiency anemia ranges from 27 to 47% (<xref rid="b30-MI-5-3-00221" ref-type="bibr">30-32</xref>). Another reason is the reluctance to select women who have had pregnancies as donors in Turkey. The female donor rate and the frequency of VVR occurrence among female donors in different countries is presented in <xref rid="tII-MI-5-3-00221" ref-type="table">Table II</xref>. The frequency of female donors varies greatly across countries. Upon reviewing these studies, it appears that factors, such as the level of development of the countries and religious beliefs play a prominent role in influencing the rate of female donors. Similar to these countries, in the authors' country, Turkey, the socio-cultural situation may be another main reason for women donating less in certain segments of society.</p><p>Setting weight limits for blood donation is critical for protecting donors from adverse effects, particularly vasovagal episodes and anemia. It has been shown that a low body weight and low blood volume are independent predictors of VVRs (<xref rid="b10-MI-5-3-00221" ref-type="bibr">10</xref>,<xref rid="b21-MI-5-3-00221" ref-type="bibr">21</xref>). Trouern-Trend <italic>et al</italic> (<xref rid="b21-MI-5-3-00221" ref-type="bibr">21</xref>) demonstrated that a low body weight increases the risk of developing VVRs. They demonstrated that VVRs developed in 4.6% of individuals with a body weight &#x0003c;120 lb and in 0.4% of those with a body weight &#x0003e;210 lb (<xref rid="b21-MI-5-3-00221" ref-type="bibr">21</xref>). Another study found that body weight was a significant determinant of the rate of vasovagal reactions in first-time blood donors (<xref rid="b22-MI-5-3-00221" ref-type="bibr">22</xref>). In general, it is accepted that the total volume of donated blood should not exceed 13% of the blood volume of the donor. For example, a donor must weigh at least 45 kg to donate 350 ml (&#x000b1;10%) of blood, and at least 50 kg to donate 450 ml (&#x000b1;10%) of blood (<xref rid="b38-MI-5-3-00221" ref-type="bibr">38</xref>). There is no specific upper weight limit for blood donation. In Turkey, the donor selection criteria require that the donor weighs &#x0003e;50 kg (<xref rid="b8-MI-5-3-00221" ref-type="bibr">8</xref>).</p><p>Psychological stresses, such as pre-donation sleep duration, a history of fainting epidodes, anxiety traits, a fear of blood and injury, and a fear of needles have been associated with VVRs (<xref rid="b24-MI-5-3-00221" ref-type="bibr">24</xref>,<xref rid="b34-MI-5-3-00221" ref-type="bibr">34-37</xref>). In their study, Takanashi <italic>et al</italic> (<xref rid="b24-MI-5-3-00221" ref-type="bibr">24</xref>) compared the records of 4,924 Japanese donors who experienced VVR with a control group of 43,948 donors who did not experience any such complications which were related to donation. As observed in their study, for both male and female donors, factors such as being a first-time donor, having a pre-donation pulse rate of &#x02265;90 beats per minute, a diastolic blood pressure &#x02264;70 mmHg, &#x0003c;6 h of sleep (compared to &#x0003e;8 h of sleep), not eating within the previous 4 h, and factors such as age, sex, body mass index, pulse rate and systolic blood pressure were all significantly associated with an increased risk of having VVRs (<xref rid="b24-MI-5-3-00221" ref-type="bibr">24</xref>).</p><p>The underlying mechanisms of VVRs include the orthostatic effects of hypovolemic static status (i.e., a decrease in blood pressure when standing up following the donation) and psychological stress related to the procedure (e.g., pain associated with needle insertion or phlebotomy) (<xref rid="b38-MI-5-3-00221" ref-type="bibr">38</xref>). Due to the complexity of the mechanisms involved, current prevention strategies target both the physiological and psychological aspects of the reaction (<xref rid="b39-MI-5-3-00221" ref-type="bibr">39</xref>).</p><p>Various strategies have been proposed to prevent VVRs. For example, the World Health Organization (WHO) recommends pre-donation hydration and the application of active muscle tension (AMT) to increase blood flow and blood pressure. The EU Domaine Project supports pre-donation hydration and AMT, as well as caffeine loading, distraction techniques, supportive care, and educational materials (<xref rid="b40-MI-5-3-00221" ref-type="bibr">40-42</xref>). Blood services worldwide have adopted various strategies to prevent VVRs, with water loading and AMT being the most common (<xref rid="b43-MI-5-3-00221" ref-type="bibr">43</xref>,<xref rid="b44-MI-5-3-00221" ref-type="bibr">44</xref>).</p><p>Compared to the empirical literature focusing on pre-donation hydration and AMT, only a limited number of studies have addressed the psychological aspects of the donation and their association with vasovagal symptoms. Studies evaluating psychological methods primarily focus on reducing stress or anxiety by providing distraction or social support during the procedure (<xref rid="b39-MI-5-3-00221" ref-type="bibr">39</xref>). In a previous study, the effectiveness of audiovisual distraction for first-time donors was investigated by classifying individuals based on their coping styles as monitoring (attending to the situation) or blunting (distracting, denying, or reinterpreting the situation) (<xref rid="b45-MI-5-3-00221" ref-type="bibr">45</xref>). Donors with blunting coping styles who were provided with a distracting environment reported significantly lower self-reported vasovagal symptoms compared to participants in the untreated control condition (<xref rid="b45-MI-5-3-00221" ref-type="bibr">45</xref>). Hanson and France (<xref rid="b46-MI-5-3-00221" ref-type="bibr">46</xref>) demonstrated that donors who were accompanied by a trained research assistant for support had lower VVR levels and were more willing to donate again compared to donors who did not receive support.</p><p>VVRs can be minimized with simple precautions. First and foremost, donor education is essential. Donors should be advised to avoid coming on an empty stomach, refrain from smoking before and after donation, avoid standing up immediately after donation (and instead sit up first), and ensure adequate fluid intake before and/or after donation. These measures will prevent the majority of cases of VVRs. However, despite these precautions, VVRs may still occur, particularly in first-time blood donors, due to psychological stress. Donors who exhibit signs of psychological stress should receive psychological support before proceeding with blood donation. Therefore, blood donation centers should have trained personnel capable of providing psychological support. Another potential factor in reducing VVR is ensuring that the blood donation environment is spacious, clean, well-ventilated, and comfortable. Additionally, a friendly attitude from the staff, effective communication, reassuring the donor, and good technical skills are important factors in reducing VVR (<xref rid="f3-MI-5-3-00221" ref-type="fig">Fig. 3</xref>).</p><p>A limitation of the present study is the lack of the evaluation of body weight, blood pressure, body temperature, oxygen saturation and psychological stress levels prior to donation. These factors could provide valuable insight into the overall health and well-being of donors, potentially affecting the donation process and outcomes. In future studies on this topic, the inclusion of these parameters would enhance the value of the research and offer a more comprehensive understanding of the factors influencing donation. Another limitation of the present study is the significantly lower number of females compared to males. However, this is not a choice of the authors, but rather a result of the general tendency of females in Turkey to donate blood.</p><p>As a result, in the present study, the frequency of VVRs was found to be 4.9%, and it was observed that VVRs developed more frequently in younger individuals and first-time donors. Although numerous intervention studies have evaluated the effectiveness of physiological and psychological methods in preventing VVRs and/or vasovagal symptoms, questions regarding the efficacy of these techniques remain. A reasonable approach may be to apply both physiological and psychological preventive methods to young first-time donors to prevent them from experiencing VVRs. This is due to the fact that those who experience VVRs during their first blood donation tend to avoid donating again, which leads to a decrease in the number of blood donors.</p></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><sec sec-type="data-availability"><title>Availability of data and materials</title><p>The data generated in the present study may be requested from the corresponding author.</p></sec><sec><title>Authors' contributions</title><p>SD was a main contributor to the conception of the study, as well as to the literature search for related studies. SD, HD and ATe were involved in the literature review, in the writing of the manuscript, and in the analysis and interpretation of the patient data. AT&#x000fc; and ATo collected data. HD and Ate confirm the authenticity of all the raw data.</p></sec><sec><title>Ethics approval and consent to participate</title><p>The present study was approved by the Necmettin Erbakan University, Ethics Committee for Non-Pharmaceutical and Non-Medical Device Research (2024-5381). Written consent was obtained from the participants.</p></sec><sec><title>Patient consent for publication</title><p>Not applicable.</p></sec><sec sec-type="COI-statement"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><ref-list><title>References</title><ref id="b1-MI-5-3-00221"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilchrist</surname><given-names>PT</given-names></name><name><surname>Ditto</surname><given-names>B</given-names></name></person-group><article-title>Sense of impending doom: Inhibitory activity in waiting blood donors who subsequently experience vasovagal symptoms</article-title><source>Biol Psychol</source><volume>104</volume><fpage>28</fpage><lpage>34</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.biopsycho.2014.11.006</pub-id><pub-id pub-id-type="pmid">25451384</pub-id>
</element-citation></ref><ref id="b2-MI-5-3-00221"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieling</surname><given-names>W</given-names></name><name><surname>Thijs</surname><given-names>RD</given-names></name><name><surname>van Dijk</surname><given-names>N</given-names></name><name><surname>Wilde</surname><given-names>AAM</given-names></name><name><surname>Benditt</surname><given-names>DG</given-names></name><name><surname>van Dijk</surname><given-names>JG</given-names></name></person-group><article-title>Symptoms and signs of syncope: A review of the link between physiology and clinical clues</article-title><source>Brain</source><volume>132</volume><fpage>2630</fpage><lpage>2642</lpage><year>2009</year><pub-id pub-id-type="doi">10.1093/brain/awp179</pub-id><pub-id pub-id-type="pmid">19587129</pub-id>
</element-citation></ref><ref id="b3-MI-5-3-00221"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomasulo</surname><given-names>P</given-names></name><name><surname>Bravo</surname><given-names>M</given-names></name><name><surname>Kamel</surname><given-names>H</given-names></name></person-group><article-title>Time course of vasovagal syncope with whole blood donation</article-title><source>ISBT Sci Ser</source><volume>5</volume><fpage>52</fpage><lpage>58</lpage><year>2010</year></element-citation></ref><ref id="b4-MI-5-3-00221"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamel</surname><given-names>H</given-names></name><name><surname>Tomasulo</surname><given-names>P</given-names></name><name><surname>Bravo</surname><given-names>M</given-names></name><name><surname>Wiltbank</surname><given-names>T</given-names></name><name><surname>Cusick</surname><given-names>R</given-names></name><name><surname>James</surname><given-names>RC</given-names></name><name><surname>Custer</surname><given-names>B</given-names></name></person-group><article-title>Delayed adverse reactions to blood donation</article-title><source>Transfusion (Paris)</source><volume>50</volume><fpage>556</fpage><lpage>565</lpage><year>2010</year><pub-id pub-id-type="doi">10.1111/j.1537-2995.2009.02397.x</pub-id><pub-id pub-id-type="pmid">19804573</pub-id>
</element-citation></ref><ref id="b5-MI-5-3-00221"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiersum-Osselton</surname><given-names>JC</given-names></name><name><surname>Marijt-van der Kreek</surname><given-names>T</given-names></name><name><surname>Brand</surname><given-names>A</given-names></name><name><surname>Veldhuizen</surname><given-names>I</given-names></name><name><surname>van der Bom</surname><given-names>JG</given-names></name><name><surname>de Kort</surname><given-names>W</given-names></name></person-group><article-title>Risk factors for complications in donors at first and repeat whole blood donation: A cohort study with assessment of the impact on donor return</article-title><source>Blood Transfus</source><volume>12 (Suppl 1)</volume><fpage>S28</fpage><lpage>S36</lpage><year>2014</year><pub-id pub-id-type="doi">10.2450/2013.0262-12</pub-id><pub-id pub-id-type="pmid">23867173</pub-id>
</element-citation></ref><ref id="b6-MI-5-3-00221"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rader</surname><given-names>AW</given-names></name><name><surname>France</surname><given-names>CR</given-names></name><name><surname>Carlson</surname><given-names>B</given-names></name></person-group><article-title>Donor retention as a function of donor reactions to whole-blood and automated double red cell collections</article-title><source>Transfusion (Paris)</source><volume>47</volume><fpage>995</fpage><lpage>1001</lpage><year>2007</year><pub-id pub-id-type="doi">10.1111/j.1537-2995.2007.01223.x</pub-id><pub-id pub-id-type="pmid">17524088</pub-id>
</element-citation></ref><ref id="b7-MI-5-3-00221"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>France</surname><given-names>CR</given-names></name><name><surname>Rader</surname><given-names>A</given-names></name><name><surname>Carlson</surname><given-names>B</given-names></name></person-group><article-title>Donors who react may not come back: Analysis of repeat donation as a function of phlebotomist ratings of vasovagal reactions</article-title><source>Transfus Apher Sci</source><volume>33</volume><fpage>99</fpage><lpage>106</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.transci.2005.02.005</pub-id><pub-id pub-id-type="pmid">16103014</pub-id>
</element-citation></ref><ref id="b8-MI-5-3-00221"><label>8</label><element-citation publication-type="journal"><comment>National Guide for Blood and Blood Components Preparation, Usage and Quality Assurance. Republic of Turkey, Ministry of Health, 2016. Available from: <ext-link xlink:href="https://shgmkanhizmetleridb.saglik.gov.tr/TR,71523/ulusal-kan-ve-kan-bilesenleri-hazirlama-kullanim-ve-kalite-guvencesi-rehberi-2016.html" ext-link-type="uri">https://shgmkanhizmetleridb.saglik.gov.tr/TR,71523/ulusal-kan-ve-kan-bilesenleri-hazirlama-kullanim-ve-kalite-guvencesi-rehberi-2016.html</ext-link>.</comment></element-citation></ref><ref id="b9-MI-5-3-00221"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiltbank</surname><given-names>TB</given-names></name><name><surname>Giordano</surname><given-names>GF</given-names></name><name><surname>Kamel</surname><given-names>H</given-names></name><name><surname>Tomasulo</surname><given-names>P</given-names></name><name><surname>Custer</surname><given-names>B</given-names></name></person-group><article-title>Faint and prefaint reactions in whole-blood donors: An analysis of predonation measurements and their predictive value</article-title><source>Transfusion</source><volume>48</volume><fpage>1799</fpage><lpage>1808</lpage><year>2008</year><pub-id pub-id-type="doi">10.1111/j.1537-2995.2008.01745.x</pub-id><pub-id pub-id-type="pmid">18482188</pub-id>
</element-citation></ref><ref id="b10-MI-5-3-00221"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>JT</given-names></name><name><surname>Ziegler</surname><given-names>DK</given-names></name><name><surname>Lai</surname><given-names>C</given-names></name><name><surname>Bayer</surname><given-names>W</given-names></name></person-group><article-title>Convulsive syncope in blood donors</article-title><source>Ann Neurol</source><volume>11</volume><fpage>525</fpage><lpage>528</lpage><year>1982</year><pub-id pub-id-type="doi">10.1002/ana.410110513</pub-id><pub-id pub-id-type="pmid">7103429</pub-id>
</element-citation></ref><ref id="b11-MI-5-3-00221"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>BH</given-names></name></person-group><article-title>Blood donor complications after whole-blood donation</article-title><source>Curr Opin Hematol</source><volume>11</volume><fpage>339</fpage><lpage>345</lpage><year>2004</year><pub-id pub-id-type="doi">10.1097/01.moh.0000142105.21058.96</pub-id><pub-id pub-id-type="pmid">15666658</pub-id>
</element-citation></ref><ref id="b12-MI-5-3-00221"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almutairi</surname><given-names>H</given-names></name><name><surname>Salam</surname><given-names>M</given-names></name><name><surname>Alajlan</surname><given-names>A</given-names></name><name><surname>Wani</surname><given-names>F</given-names></name><name><surname>Al-Shammari</surname><given-names>B</given-names></name><name><surname>Al-Surimi</surname><given-names>K</given-names></name></person-group><article-title>Incidence, predictors and severity of adverse events among whole blood donors</article-title><source>PLoS One</source><volume>12</volume><issue>e0179831</issue><year>2017</year><pub-id pub-id-type="doi">10.1371/journal.pone.0179831</pub-id><pub-id pub-id-type="pmid">28732090</pub-id>
</element-citation></ref><ref id="b13-MI-5-3-00221"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crocco</surname><given-names>I</given-names></name><name><surname>Franchini</surname><given-names>M</given-names></name><name><surname>Garozzo</surname><given-names>G</given-names></name><name><surname>Gandini</surname><given-names>AR</given-names></name><name><surname>Gandini</surname><given-names>G</given-names></name><name><surname>Bonomo</surname><given-names>P</given-names></name><name><surname>Aprili</surname><given-names>G</given-names></name></person-group><article-title>Adverse reactions in blood and apheresis donors: Experience from two Italian transfusion centres</article-title><source>Blood Transfus</source><volume>7</volume><fpage>35</fpage><lpage>38</lpage><year>2009</year><pub-id pub-id-type="doi">10.2450/2008.0018-08</pub-id><pub-id pub-id-type="pmid">19290078</pub-id>
</element-citation></ref><ref id="b14-MI-5-3-00221"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philip</surname><given-names>J</given-names></name><name><surname>Sarkar</surname><given-names>R</given-names></name><name><surname>Jain</surname><given-names>N</given-names></name></person-group><article-title>A single-centre study of vasovagal reaction in blood donors: Influence of age, sex, donation status, weight, total blood volume and volume of blood collected</article-title><source>Asian J Transfus Sci</source><volume>8</volume><fpage>43</fpage><lpage>46</lpage><year>2014</year><pub-id pub-id-type="doi">10.4103/0973-6247.126690</pub-id><pub-id pub-id-type="pmid">24678174</pub-id>
</element-citation></ref><ref id="b15-MI-5-3-00221"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sultan</surname><given-names>S</given-names></name><name><surname>Baig</surname><given-names>MA</given-names></name><name><surname>Irfan</surname><given-names>SM</given-names></name><name><surname>Ahmed</surname><given-names>SI</given-names></name><name><surname>Hasan</surname><given-names>S</given-names></name></person-group><article-title>Adverse reactions in allogeneic blood donors: A tertiary care experience from a developing country</article-title><source>Oman Med J</source><volume>31</volume><fpage>124</fpage><lpage>128</lpage><year>2016</year><pub-id pub-id-type="doi">10.5001/omj.2016.24</pub-id><pub-id pub-id-type="pmid">27168923</pub-id>
</element-citation></ref><ref id="b16-MI-5-3-00221"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhardt</surname><given-names>T</given-names></name><name><surname>Dimanski</surname><given-names>B</given-names></name><name><surname>Karl</surname><given-names>R</given-names></name><name><surname>Sievert</surname><given-names>U</given-names></name><name><surname>Karl</surname><given-names>A</given-names></name><name><surname>H&#x000fc;bler</surname><given-names>C</given-names></name><name><surname>Tonn</surname><given-names>T</given-names></name><name><surname>Sopvinik</surname><given-names>I</given-names></name><name><surname>Ertl</surname><given-names>H</given-names></name><name><surname>Moog</surname><given-names>R</given-names></name></person-group><article-title>Donor vigilance data of a blood transfusion service: A multicenter analysis</article-title><source>Transfus Apher Sci</source><volume>53</volume><fpage>180</fpage><lpage>184</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.transci.2015.03.014</pub-id><pub-id pub-id-type="pmid">26074050</pub-id>
</element-citation></ref><ref id="b17-MI-5-3-00221"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Assarian</surname><given-names>Z</given-names></name><name><surname>Haghighi</surname><given-names>BA</given-names></name><name><surname>Javadi</surname><given-names>I</given-names></name><name><surname>Fotouhi</surname><given-names>A</given-names></name><name><surname>Seighali</surname><given-names>F</given-names></name><name><surname>Akbari</surname><given-names>N</given-names></name></person-group><article-title>Risk factors for vasovagal reactions during blood donation</article-title><source>Sci J Iran Blood Transfus Organ</source><volume>7</volume><fpage>221</fpage><lpage>226</lpage><year>2011</year></element-citation></ref><ref id="b18-MI-5-3-00221"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gon&#x000e7;alez</surname><given-names>TT</given-names></name><name><surname>Sabino</surname><given-names>EC</given-names></name><name><surname>Schlumpf</surname><given-names>KS</given-names></name><name><surname>Wright</surname><given-names>DJ</given-names></name><name><surname>Leao</surname><given-names>S</given-names></name><name><surname>Sampaio</surname><given-names>D</given-names></name><name><surname>Takecian</surname><given-names>PL</given-names></name><name><surname>Proietti</surname><given-names>AB</given-names></name><name><surname>Murphy</surname><given-names>E</given-names></name><name><surname>Busch</surname><given-names>M</given-names></name><etal/></person-group><article-title>Vasovagal reactions in whole blood donors at three REDS-II blood centers in Brazil</article-title><source>Transfusion</source><volume>52</volume><fpage>1070</fpage><lpage>1078</lpage><year>2012</year><pub-id pub-id-type="doi">10.1111/j.1537-2995.2011.03432.x</pub-id><pub-id pub-id-type="pmid">22073941</pub-id>
</element-citation></ref><ref id="b19-MI-5-3-00221"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eder</surname><given-names>AF</given-names></name><name><surname>Hillyer</surname><given-names>CD</given-names></name><name><surname>Dy</surname><given-names>BA</given-names></name><name><surname>Notari</surname><given-names>EP IV</given-names></name><name><surname>Benjamin</surname><given-names>RJ</given-names></name></person-group><article-title>Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds</article-title><source>JAMA</source><volume>299</volume><fpage>2279</fpage><lpage>2286</lpage><year>2008</year><pub-id pub-id-type="doi">10.1001/jama.299.19.2279</pub-id><pub-id pub-id-type="pmid">18492969</pub-id>
</element-citation></ref><ref id="b20-MI-5-3-00221"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman</surname><given-names>M</given-names></name><name><surname>Osmond</surname><given-names>L</given-names></name><name><surname>Yi</surname><given-names>QL</given-names></name><name><surname>Cameron-Choi</surname><given-names>K</given-names></name><name><surname>O'Brien</surname><given-names>SF</given-names></name></person-group><article-title>Frequency and risk factors for donor reactions in an anonymous blood donor survey</article-title><source>Transfusion</source><volume>53</volume><fpage>1979</fpage><lpage>1984</lpage><year>2013</year><pub-id pub-id-type="doi">10.1111/trf.12011</pub-id><pub-id pub-id-type="pmid">23228195</pub-id>
</element-citation></ref><ref id="b21-MI-5-3-00221"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trouern-Trend</surname><given-names>JJ</given-names></name><name><surname>Cable</surname><given-names>RG</given-names></name><name><surname>Badon</surname><given-names>SJ</given-names></name><name><surname>Newman</surname><given-names>BH</given-names></name><name><surname>Popovsky</surname><given-names>MA</given-names></name></person-group><article-title>A case-controlled multicenter study of vasovagal reactions in blood donors: Influence of sex, age, donation status, weight, blood pressure, and pulse</article-title><source>Transfusion</source><volume>39</volume><fpage>316</fpage><lpage>320</lpage><year>1999</year><pub-id pub-id-type="doi">10.1046/j.1537-2995.1999.39399219291.x</pub-id><pub-id pub-id-type="pmid">10204597</pub-id>
</element-citation></ref><ref id="b22-MI-5-3-00221"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>BH</given-names></name></person-group><article-title>Vasovagal reaction rates and body weight: Findings in high- and low-risk populations</article-title><source>Transfusion</source><volume>43</volume><fpage>1084</fpage><lpage>1088</lpage><year>2003</year><pub-id pub-id-type="doi">10.1046/j.1537-2995.2003.00478.x</pub-id><pub-id pub-id-type="pmid">12869114</pub-id>
</element-citation></ref><ref id="b23-MI-5-3-00221"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>M</given-names></name><name><surname>Kamel</surname><given-names>H</given-names></name><name><surname>Custer</surname><given-names>B</given-names></name><name><surname>Tomasulo</surname><given-names>P</given-names></name></person-group><article-title>Factors associated with fainting-before, during and after whole blood donation</article-title><source>Vox Sang</source><volume>101</volume><fpage>303</fpage><lpage>312</lpage><year>2011</year><pub-id pub-id-type="doi">10.1111/j.1423-0410.2011.01494.x</pub-id><pub-id pub-id-type="pmid">21535440</pub-id>
</element-citation></ref><ref id="b24-MI-5-3-00221"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takanashi</surname><given-names>M</given-names></name><name><surname>Odajima</surname><given-names>T</given-names></name><name><surname>Aota</surname><given-names>S</given-names></name><name><surname>Sudoh</surname><given-names>M</given-names></name><name><surname>Yamaga</surname><given-names>Y</given-names></name><name><surname>Ono</surname><given-names>Y</given-names></name><name><surname>Yoshinaga</surname><given-names>K</given-names></name><name><surname>Motoji</surname><given-names>T</given-names></name><name><surname>Matsuzaki</surname><given-names>K</given-names></name><name><surname>Satake</surname><given-names>M</given-names></name><etal/></person-group><article-title>Risk factor analysis of vasovagal reaction from blood donation</article-title><source>Transfus Aphere Sci</source><volume>47</volume><fpage>319</fpage><lpage>325</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.transci.2012.04.002</pub-id><pub-id pub-id-type="pmid">22647682</pub-id>
</element-citation></ref><ref id="b25-MI-5-3-00221"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ke</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Xiong</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name></person-group><article-title>Long-term poor sleep quality is associated with adverse donor reactions in college students in Central China: A population-based cross-sectional study</article-title><source>Vox Sang</source><volume>118</volume><fpage>455</fpage><lpage>462</lpage><year>2023</year><pub-id pub-id-type="doi">10.1111/vox.13438</pub-id><pub-id pub-id-type="pmid">37191246</pub-id>
</element-citation></ref><ref id="b26-MI-5-3-00221"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eder</surname><given-names>AF</given-names></name><name><surname>Notari</surname><given-names>EP IV</given-names></name><name><surname>Dodd</surname><given-names>RY</given-names></name></person-group><article-title>Do reactions after whole blood donation predict syncope on return donation?</article-title><source>Transfusion</source><volume>52</volume><fpage>2570</fpage><lpage>2576</lpage><year>2012</year><pub-id pub-id-type="doi">10.1111/j.1537-2995.2012.03666.x</pub-id><pub-id pub-id-type="pmid">22536827</pub-id>
</element-citation></ref><ref id="b27-MI-5-3-00221"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudokaite</surname><given-names>J</given-names></name><name><surname>Ong</surname><given-names>LLS</given-names></name><name><surname>Ertugrul</surname><given-names>IO</given-names></name><name><surname>Janssen</surname><given-names>MP</given-names></name><name><surname>Veld</surname><given-names>EMJ</given-names></name></person-group><article-title>Predicting vasovagal reactions to needles with anticipatory facial temperature profiles</article-title><source>Sci Rep</source><volume>13</volume><issue>9667</issue><year>2023</year><pub-id pub-id-type="doi">10.1038/s41598-023-36207-z</pub-id><pub-id pub-id-type="pmid">37316637</pub-id>
</element-citation></ref><ref id="b28-MI-5-3-00221"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>BH</given-names></name><name><surname>Pichette</surname><given-names>S</given-names></name><name><surname>Pichette</surname><given-names>D</given-names></name><name><surname>Dzaka</surname><given-names>E</given-names></name></person-group><article-title>Adverse effects in blood donors after whole-blood donation: A study of 1000 blood donors interviewed 3 weeks after whole-blood donation</article-title><source>Transfusion</source><volume>43</volume><fpage>598</fpage><lpage>603</lpage><year>2003</year><pub-id pub-id-type="doi">10.1046/j.1537-2995.2003.00368.x</pub-id><pub-id pub-id-type="pmid">12702180</pub-id>
</element-citation></ref><ref id="b29-MI-5-3-00221"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>BH</given-names></name><name><surname>Satz</surname><given-names>SL</given-names></name><name><surname>Janowicz</surname><given-names>NM</given-names></name><name><surname>Siegfried</surname><given-names>BA</given-names></name></person-group><article-title>Donor reactions in high-school donors: The effects of sex, weight, and collection volume</article-title><source>Transfusion</source><volume>46</volume><fpage>284</fpage><lpage>288</lpage><year>2006</year><pub-id pub-id-type="doi">10.1111/j.1537-2995.2006.00713.x</pub-id><pub-id pub-id-type="pmid">16441608</pub-id>
</element-citation></ref><ref id="b30-MI-5-3-00221"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>I</given-names></name><name><surname>Parker</surname><given-names>HM</given-names></name><name><surname>Rangan</surname><given-names>A</given-names></name><name><surname>Prvan</surname><given-names>T</given-names></name><name><surname>Cook</surname><given-names>RL</given-names></name><name><surname>Donges</surname><given-names>CE</given-names></name><name><surname>Steinbeck</surname><given-names>KS</given-names></name><name><surname>O'Dwyer</surname><given-names>NJ</given-names></name><name><surname>Cheng</surname><given-names>HL</given-names></name><name><surname>Franklin</surname><given-names>JL</given-names></name><name><surname>O'Connor</surname><given-names>HT</given-names></name></person-group><article-title>Association between haem and non-haem iron intake and serum ferritin in healthy young women</article-title><source>Nutrients</source><volume>10</volume><issue>81</issue><year>2018</year><pub-id pub-id-type="doi">10.3390/nu10010081</pub-id><pub-id pub-id-type="pmid">29329258</pub-id>
</element-citation></ref><ref id="b31-MI-5-3-00221"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwalla</surname><given-names>N</given-names></name><name><surname>Al Dhaheri</surname><given-names>AS</given-names></name><name><surname>Radwan</surname><given-names>H</given-names></name><name><surname>Alfawaz</surname><given-names>HA</given-names></name><name><surname>Fouda</surname><given-names>MA</given-names></name><name><surname>Al-Daghri</surname><given-names>NM</given-names></name><name><surname>Zaghloul</surname><given-names>S</given-names></name><name><surname>Blumberg</surname><given-names>JB</given-names></name></person-group><article-title>The prevalence of micronutrient deficiencies and inadequacies in the Middle East and approaches to interventions</article-title><source>Nutrients</source><volume>9</volume><issue>229</issue><year>2017</year><pub-id pub-id-type="doi">10.3390/nu9030229</pub-id><pub-id pub-id-type="pmid">28273802</pub-id>
</element-citation></ref><ref id="b32-MI-5-3-00221"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Santolo</surname><given-names>M</given-names></name><name><surname>Stel</surname><given-names>G</given-names></name><name><surname>Banfi</surname><given-names>G</given-names></name><name><surname>Gonano</surname><given-names>F</given-names></name><name><surname>Cauci</surname><given-names>S</given-names></name></person-group><article-title>Anemia and iron status in young fertile non-professional female athletes</article-title><source>Eur J Appl Physiol</source><volume>102</volume><fpage>703</fpage><lpage>709</lpage><year>2008</year><pub-id pub-id-type="doi">10.1007/s00421-007-0647-9</pub-id><pub-id pub-id-type="pmid">18092176</pub-id>
</element-citation></ref><ref id="b33-MI-5-3-00221"><label>33</label><element-citation publication-type="journal"><comment>Blood Donor Selection: Guidelines on assessing donor suitability for blood donation. World Health Organization, p118, 2013.</comment></element-citation></ref><ref id="b34-MI-5-3-00221"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meade</surname><given-names>MA</given-names></name><name><surname>France</surname><given-names>CR</given-names></name><name><surname>Peterson</surname><given-names>LM</given-names></name></person-group><article-title>Predicting vasovagal reactions in volunteer blood donors</article-title><source>J Psychosom Res</source><volume>40</volume><fpage>495</fpage><lpage>501</lpage><year>1996</year><pub-id pub-id-type="doi">10.1016/0022-3999(95)00639-7</pub-id><pub-id pub-id-type="pmid">8803858</pub-id>
</element-citation></ref><ref id="b35-MI-5-3-00221"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ditto</surname><given-names>B</given-names></name><name><surname>France</surname><given-names>CR</given-names></name></person-group><article-title>Vasovagal symptoms mediate the relationship between predonation anxiety and subsequent blood donation in female volunteers</article-title><source>Transfusion</source><volume>46</volume><fpage>1006</fpage><lpage>1010</lpage><year>2006</year><pub-id pub-id-type="doi">10.1111/j.1537-2995.2006.00835.x</pub-id><pub-id pub-id-type="pmid">16734818</pub-id>
</element-citation></ref><ref id="b36-MI-5-3-00221"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ditto</surname><given-names>B</given-names></name><name><surname>Gilchrist</surname><given-names>PT</given-names></name><name><surname>Holly</surname><given-names>CD</given-names></name></person-group><article-title>Fear-related predictors of vasovagal symptoms during blood donation: It's in the blood</article-title><source>J Behav Med</source><volume>35</volume><fpage>393</fpage><lpage>399</lpage><year>2012</year><pub-id pub-id-type="doi">10.1007/s10865-011-9366-0</pub-id><pub-id pub-id-type="pmid">21751041</pub-id>
</element-citation></ref><ref id="b37-MI-5-3-00221"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>France</surname><given-names>CR</given-names></name><name><surname>France</surname><given-names>JL</given-names></name><name><surname>Himawan</surname><given-names>LK</given-names></name><name><surname>Stephens</surname><given-names>KY</given-names></name><name><surname>Frame-Brown</surname><given-names>TA</given-names></name><name><surname>Venable</surname><given-names>GA</given-names></name><name><surname>Menitove</surname><given-names>JE</given-names></name></person-group><article-title>How afraid are you of having blood drawn from your arm? A simple fear question predicts vasovagal reactions without causing them among high school donors</article-title><source>Transfusion</source><volume>53</volume><fpage>315</fpage><lpage>321</lpage><year>2013</year><pub-id pub-id-type="doi">10.1111/j.1537-2995.2012.03726.x</pub-id><pub-id pub-id-type="pmid">22670781</pub-id>
</element-citation></ref><ref id="b38-MI-5-3-00221"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieling</surname><given-names>W</given-names></name><name><surname>France</surname><given-names>CR</given-names></name><name><surname>van Dijk</surname><given-names>N</given-names></name><name><surname>Kamel</surname><given-names>H</given-names></name><name><surname>Thijs</surname><given-names>RD</given-names></name><name><surname>Tomasulo</surname><given-names>P</given-names></name></person-group><article-title>Physiologic strategies to prevent fainting responses during or after whole blood donation</article-title><source>Transfusion</source><volume>51</volume><fpage>2727</fpage><lpage>2738</lpage><year>2011</year><pub-id pub-id-type="doi">10.1111/j.1537-2995.2011.03202.x</pub-id><pub-id pub-id-type="pmid">21645008</pub-id>
</element-citation></ref><ref id="b39-MI-5-3-00221"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thijsen</surname><given-names>A</given-names></name><name><surname>Masser</surname><given-names>B</given-names></name></person-group><article-title>Vasovagal reactions in blood donors: Risks, prevention and management</article-title><source>Transfus Med</source><volume>29 (Suppl 1)</volume><fpage>S13</fpage><lpage>S22</lpage><year>2019</year><pub-id pub-id-type="doi">10.1111/tme.12488</pub-id><pub-id pub-id-type="pmid">29148259</pub-id>
</element-citation></ref><ref id="b40-MI-5-3-00221"><label>40</label><element-citation publication-type="journal"><comment>World Health Organization. (2012). Blood Donor Selection: Guidelines on Assessing Donor Suitability for Blood Donation. World Health Organization. Available from: <ext-link xlink:href="https://iris.who.int/handle/10665/76724" ext-link-type="uri">https://iris.who.int/handle/10665/76724</ext-link>.</comment></element-citation></ref><ref id="b41-MI-5-3-00221"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Kort</surname><given-names>WVI</given-names></name></person-group><comment>Donor management manual. DOMAINE project c/o Sanquin Blood Supply Foundation. 2010. Available from: <ext-link xlink:href="https://www.sanquin.org/binaries/content/assets/en/research/donor-studies/en-donor-mangement-manual-part-1.pdf" ext-link-type="uri">https://www.sanquin.org/binaries/content/assets/en/research/donor-studies/en-donor-mange ment-manual-part-1.pdf</ext-link>. Accessed February 6, 2023.</comment></element-citation></ref><ref id="b42-MI-5-3-00221"><label>42</label><element-citation publication-type="journal"><comment>Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. Guidelines for the Blood Transfusion Services. 2013. Available from: <ext-link xlink:href="https://www.transfusionguidelines.org/dsg" ext-link-type="uri">https://www.transfusionguid elines.org/dsg</ext-link>. Accessed February 6, 2023.</comment></element-citation></ref><ref id="b43-MI-5-3-00221"><label>43</label><element-citation publication-type="journal"><comment>Tips For A Successful Blood Donation | Red Cross Blood Services. Available from: <ext-link xlink:href="https://www.redcrossblood.org/donate-blood/blood-donation-process/before-during-after.html" ext-link-type="uri">https://www.redcrossblood.org/donate-blood/blood-donat ion-process/before-during-after.html</ext-link>. Accessed February 6, 2023.</comment></element-citation></ref><ref id="b44-MI-5-3-00221"><label>44</label><element-citation publication-type="journal"><comment>Blood donation process at Canadian Blood Services. Available from: <ext-link xlink:href="https://www.blood.ca/en/blood/donating-blood/donation-process" ext-link-type="uri">https://www.blood.ca/en/blood/donating-blood/donation-process</ext-link>. Accessed February 6, 2023.</comment></element-citation></ref><ref id="b45-MI-5-3-00221"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonk</surname><given-names>VA</given-names></name><name><surname>France</surname><given-names>CR</given-names></name><name><surname>Taylor</surname><given-names>BK</given-names></name></person-group><article-title>Distraction reduces self-reported physiological reactions to blood donation in novice donors with a blunting coping style</article-title><source>Psychosom Med</source><volume>63</volume><fpage>447</fpage><lpage>452</lpage><year>2001</year><pub-id pub-id-type="doi">10.1097/00006842-200105000-00014</pub-id><pub-id pub-id-type="pmid">11382272</pub-id>
</element-citation></ref><ref id="b46-MI-5-3-00221"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>SA</given-names></name><name><surname>France</surname><given-names>CR</given-names></name></person-group><article-title>Social support attenuates presyncopal reactions to blood donation</article-title><source>Transfusion</source><volume>49</volume><fpage>843</fpage><lpage>850</lpage><year>2009</year><pub-id pub-id-type="doi">10.1111/j.1537-2995.2008.02057.x</pub-id><pub-id pub-id-type="pmid">19170990</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="f1-MI-5-3-00221"><label>Figure 1</label><caption><p>The frequency of VVR development based on donation history. VVR, vasovagal reaction.</p></caption><graphic xlink:href="mi-05-03-00221-g00" position="float"/></fig><fig position="float" id="f2-MI-5-3-00221"><label>Figure 2</label><caption><p>Association between the timing of VVR development and donation history. VVR, vasovagal reaction.</p></caption><graphic xlink:href="mi-05-03-00221-g01" position="float"/></fig><fig position="float" id="f3-MI-5-3-00221"><label>Figure 3</label><caption><p>Preventive strategies for at-risk blood donors.</p></caption><graphic xlink:href="mi-05-03-00221-g02" position="float"/></fig><table-wrap position="float" id="tI-MI-5-3-00221"><label>Table I</label><caption><p>Epidemiological and laboratory comparison of the donors with and without VVRs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Parameter</th><th align="center" valign="middle" rowspan="1" colspan="1">VVR (-) (n:705)</th><th align="center" valign="middle" rowspan="1" colspan="1">VVR (+) (n:37)</th><th align="center" valign="middle" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sex, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">0.072<sup><xref rid="tfna-MI-5-3-00221" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Female</td><td align="center" valign="middle" rowspan="1" colspan="1">62 (8.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (18.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Male</td><td align="center" valign="middle" rowspan="1" colspan="1">643 (91.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (81.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Additional disease, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">NS<sup><xref rid="tfna-MI-5-3-00221" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (2.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;No</td><td align="center" valign="middle" rowspan="1" colspan="1">687 (97.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">37(100)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Fasting status, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">NS<sup><xref rid="tfna-MI-5-3-00221" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (1,6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;No</td><td align="center" valign="middle" rowspan="1" colspan="1">694 (98.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">37</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Donation history</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.010<sup><xref rid="tfna-MI-5-3-00221" ref-type="table-fn">a</xref></sup></bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;First-time</td><td align="center" valign="middle" rowspan="1" colspan="1">107 (15.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (32.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Repeat</td><td align="center" valign="middle" rowspan="1" colspan="1">598 (84.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (67.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (median, range)</td><td align="center" valign="middle" rowspan="1" colspan="1">36 (18-67)</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (18-56)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.04<sup><xref rid="tfnb-MI-5-3-00221" ref-type="table-fn">b</xref></sup></bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Time since last meal (h)</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (0.5-12)</td><td align="center" valign="middle" rowspan="1" colspan="1">1 (0.5-4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.29<sup><xref rid="tfnb-MI-5-3-00221" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">No. of blood donations</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (0-80)</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (0-20)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001<sup><xref rid="tfnb-MI-5-3-00221" ref-type="table-fn">b</xref></sup></bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leukocyte count (mm<sup>3</sup>)</td><td align="center" valign="middle" rowspan="1" colspan="1">7,745 (4,100-11,800)</td><td align="center" valign="middle" rowspan="1" colspan="1">7,550 (5,400-12,500)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.611<sup><xref rid="tfnb-MI-5-3-00221" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hemoglobin (g/dl)</td><td align="center" valign="middle" rowspan="1" colspan="1">15.3 (12,4-18)</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (12.5-17.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.072<sup><xref rid="tfnb-MI-5-3-00221" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hematocrit (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">44.6 (36.1-52.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">43.6 (28.2-50.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.064<sup><xref rid="tfnb-MI-5-3-00221" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Platelet count (x10<sup>3</sup>/&#x000b5;l)</td><td align="center" valign="middle" rowspan="1" colspan="1">277.5 (112-475)</td><td align="center" valign="middle" rowspan="1" colspan="1">294 (122-393)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.79<sup><xref rid="tfnb-MI-5-3-00221" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">No. of donation times, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">0.010<sup><xref rid="tfna-MI-5-3-00221" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;First donation</td><td align="center" valign="middle" rowspan="1" colspan="1">107 (15.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (32.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Multiple donations</td><td align="center" valign="middle" rowspan="1" colspan="1">598 (84.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (67.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">The timing of VVRsc, n (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">0.027<sup><xref rid="tfna-MI-5-3-00221" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;During the donation (n=14)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;First donation</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Multiple donations</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (57.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;After the donation (n=23)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (42.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;First donation</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;Multiple donations</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (17.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">19 (82.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn><p>P-values in bold font indicate statistically significant differences (P&#x0003c;0.05). NS, not significant. Data were analyzed using</p></fn><fn id="tfna-MI-5-3-00221"><p><sup>a</sup>Fisher's exact test or</p></fn><fn id="tfnb-MI-5-3-00221"><p><sup>b</sup>Mann-Whitney U test. VVR, vasovagal reaction.</p></fn><fn id="tfnc-MI-5-3-00221"><p><sup>c</sup>Regarding patients with VVRs. VVRs, vasovagal reactions.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tII-MI-5-3-00221"><label>Table II</label><caption><p>Incidence of vasovagal reactions in blood donation in different countries worldwide.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1">Country (year of publication)</th><th align="center" valign="middle" rowspan="1" colspan="1">Sample size</th><th align="center" valign="middle" rowspan="1" colspan="1">% of bood donation in females</th><th align="center" valign="middle" rowspan="1" colspan="1">% of females developing VVR</th><th align="center" valign="middle" rowspan="1" colspan="1">% of blood donation in first donors</th><th align="center" valign="middle" rowspan="1" colspan="1">% of VVR improving in first-time donors</th><th align="center" valign="middle" rowspan="1" colspan="1">Incidence of VVR (%)</th><th align="center" valign="middle" rowspan="1" colspan="1">(Refs.)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">USA (2008)</td><td align="center" valign="middle" rowspan="1" colspan="1">422,231</td><td align="center" valign="middle" rowspan="1" colspan="1">57.9</td><td align="center" valign="middle" rowspan="1" colspan="1">1.86</td><td align="center" valign="middle" rowspan="1" colspan="1">24.6</td><td align="center" valign="middle" rowspan="1" colspan="1">2.75</td><td align="center" valign="middle" rowspan="1" colspan="1">1.43</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="b9-MI-5-3-00221" ref-type="bibr">9</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">USA (2010)</td><td align="center" valign="middle" rowspan="1" colspan="1">793,293</td><td align="center" valign="middle" rowspan="1" colspan="1">48</td><td align="center" valign="middle" rowspan="1" colspan="1">0.65</td><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">0.89</td><td align="center" valign="middle" rowspan="1" colspan="1">0.41</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="b4-MI-5-3-00221" ref-type="bibr">4</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Saudi Arabia (2017)</td><td align="center" valign="middle" rowspan="1" colspan="1">18,936</td><td align="center" valign="middle" rowspan="1" colspan="1">1.4</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2</td><td align="center" valign="middle" rowspan="1" colspan="1">47</td><td align="center" valign="middle" rowspan="1" colspan="1">1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="b12-MI-5-3-00221" ref-type="bibr">12</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Italy (2009)</td><td align="center" valign="middle" rowspan="1" colspan="1">183,855</td><td align="center" valign="middle" rowspan="1" colspan="1">8.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">19.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="b13-MI-5-3-00221" ref-type="bibr">13</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">India (2014)</td><td align="center" valign="middle" rowspan="1" colspan="1">88,201</td><td align="center" valign="middle" rowspan="1" colspan="1">3.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">35.8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">1.23</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="b14-MI-5-3-00221" ref-type="bibr">14</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Pakistan (2016)</td><td align="center" valign="middle" rowspan="1" colspan="1">41,579</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">1.03</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="b15-MI-5-3-00221" ref-type="bibr">15</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Germany (2015)</td><td align="center" valign="middle" rowspan="1" colspan="1">928,411</td><td align="center" valign="middle" rowspan="1" colspan="1">47.8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x000a0;</td><td align="center" valign="middle" rowspan="1" colspan="1">8.2</td><td align="center" valign="middle" rowspan="1" colspan="1">2.78</td><td align="center" valign="middle" rowspan="1" colspan="1">0.76</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="b16-MI-5-3-00221" ref-type="bibr">16</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Iran (2011)</td><td align="center" valign="middle" rowspan="1" colspan="1">5,285</td><td align="center" valign="middle" rowspan="1" colspan="1">4.4</td><td align="center" valign="middle" rowspan="1" colspan="1">8.6</td><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">5.6</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="b17-MI-5-3-00221" ref-type="bibr">17</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Brazil (2012)</td><td align="center" valign="middle" rowspan="1" colspan="1">724,861</td><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">3.39</td><td align="center" valign="middle" rowspan="1" colspan="1">31.5</td><td align="center" valign="middle" rowspan="1" colspan="1">4.28</td><td align="center" valign="middle" rowspan="1" colspan="1">2.2</td><td align="center" valign="middle" rowspan="1" colspan="1">(<xref rid="b18-MI-5-3-00221" ref-type="bibr">18</xref>)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Turkey (2025)</td><td align="center" valign="middle" rowspan="1" colspan="1">742</td><td align="center" valign="middle" rowspan="1" colspan="1">9.8</td><td align="center" valign="middle" rowspan="1" colspan="1">10.1</td><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">4.9</td><td align="center" valign="middle" rowspan="1" colspan="1">Present study</td></tr></tbody></table></table-wrap></floats-group></article>